Literature DB >> 7527007

Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites.

J Clària1, W Jiménez, J Ros, M Rigol, P Angeli, V Arroyo, F Rivera, J Rodés.   

Abstract

To assess whether aortic vessels of rats with cirrhosis and ascites possess an enhanced vascular response to endothelium-derived, nitric oxide-dependent vasodilators, we performed relaxation studies in isolated aortic rings of 21 control rats and 24 rats with carbon tetrachloride-induced cirrhosis and ascites. We carried out studies after contracting the vessels with norepinephrine. We measured endothelium-dependent vasodilator response by administering increasing concentrations of acetylcholine (10(-6) to 10(-2) mol/L) and ADP (10(-7) to 10(-4) mol/L). We evaluated endothelium-independent response by giving increased concentration of sodium nitrite (10(-5) to 10(-2) mol/L). The maximal absolute tension developed in response to norepinephrine was significantly decreased in cirrhotic rings (816 +/- 72 mg, p < 0.025) compared with control (1,425 +/- 75 mg) rings. Dose-response curves for endothelium-dependent vasodilators were shifted to the left in aortic rings of cirrhotic rats, and EC50 for acetylcholine and ADP were significantly decreased in cirrhotic (0.8 +/- 0.15 mmol/L and 0.42 +/- 0.16 mumol/L, p < 0.025 and p < 0.01, respectively) than in control rings (1.91 +/- 0.33 mmol/L and 3.09 +/- 0.82 mumol/L). In both acetylcholine- and ADP-stimulated vessels, differences between cirrhotic and control rings disappeared after nitric oxide synthesis inhibition with N omega-nitro-L-arginine (10(-4) mol/L). No difference in the relaxing effect of sodium nitrite was observed between cirrhotic and control rings. These results therefore demonstrate for the first time enhanced in vitro vascular responsiveness to nitric oxide-dependent vasodilators in rats with cirrhosis and ascites, giving further support to the concept that nitric oxide activity is increased in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527007     DOI: 10.1002/hep.1840200635

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 2.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

3.  Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension.

Authors:  Lukas Moleda; Lars Jurzik; Matthias Froh; Erwin Gäbele; Claus Hellerbrand; Rainer H Straub; Jürgen Schölmerich; Reiner Wiest
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

4.  Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.

Authors:  L Moreno; M A Martínez-Cuesta; J M Piqué; J Bosch; J V Esplugues
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

5.  Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.

Authors:  C M Fernández-Rodriguez; J Prieto; J Quiroga; J M Zozaya; A Andrade; C Rodriguez-Ortigosa
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats.

Authors:  Y Li; H Liu; S A Gaskari; D-M McCafferty; S S Lee
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

7.  Adenosine A(2A) receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits.

Authors:  M T Villa de Brito; A Canto; J H Duarte Correia; R A Cunha; M C Marques
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

8.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

9.  Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.

Authors:  Guillermo Fernández-Varo; Josefa Ros; Manuel Morales-Ruiz; Pilar Cejudo-Martín; Vicente Arroyo; Manel Solé; Francisca Rivera; Juan Rodés; Wladimiro Jiménez
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

Review 10.  Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.

Authors:  HongQun Liu; Seyed Ali Gaskari; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.